Abstract Introduction Spontaneous coronary artery dissection (SCAD) is a common cause of Myocardial infarction (MI) in women less than 50 years of age (1). SCAD has a high recurrent rate, and beta blockers are the only drug shown to reduce the recurrence of SCAD. However, in our clinical practice, we could not use beta-blockers in some of our patients due to sinus bradycardia of unclear cause. Therefore, we planned to study if SCAD could cause Bradycardia. Purpose To determine if Bradycardia is associated with SCAD. Methodology Utilising the National Inpatient Sample (NIS) from 2016 to 2020, we performed a multivariable logistic regression analysis to determine if SCAD was independently associated with Bradycardia (ICD-10 code R0.01) among adults. SCAD was defined as coronary artery dissection (ICD-10 code I25.42) after excluding patients who had PCI. Results A- A total of 2,561,434 (95% CI 2,526,646-2,596,222) weighted hospitalisations with Bradycardia and 18,049 (95% CI 17,288-18,811) with SCAD was included. Bradycardia was present in 5.2% (95% CI 4.6-6) of patients with SCAD and 1.7% (95% 1.7-1.7) in patients without SCAD. After adjusting for relevant causes of Bradycardia, SCAD was highly associated with Bradycardia (OR 3.04, 95% CI 2.61-3.55). Among all the risk factors studied, SCAD showed the 2nd highest strength of association (Table 1). Discussion We report the first described association of SCAD with Bradycardia in literature. Although the prevalence of Bradycardia with SCAD in our study is only 5.2%, Bradycardia is frequently not coded, and we suspect the true frequency of Bradycardia in SCAD is much higher. The exact mechanism for this association is unclear. Although the frequency of beta-blocker use is not available in our study, several other conditions, such as ischemic heart disease and cardiomyopathy, which involve more frequent beta-blocker use, did not show a degree of association as strong as SCAD with bradycardia. Therefore, we hypothesize Bradycardia could be from SCAD itself, and the current ongoing BA-SCAD (Beta-blockers and Antiplatelet agents in patients with Spontaneous Coronary Artery Dissection) trial could shed light on this association (2).